Vilazodone | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Vilazodone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 11 Listed Suppliers, $ API Reference Price

INTERMEDIATES

26 Intermediate Suppliers

26 Intermediate Suppliers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 3 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 3 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 5 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 20 Kerry, 9 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 9 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 20 Coating Systems & Additives, 14 Thickeners and Stabilizers, 12 Controlled & Modified Release, 12 Lubricants & Glidants, 11 Direct Compression, 9 Granulation, 8 Topical, 7 Co-Processed Excipients, 5 Disintegrants & Superdisintegrants, 4 Film Formers & Plasticizers, 4 Solubilizers, 4 Parenteral, 3 Taste Masking, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Coloring Agents, 2 Chewable & Orodispersible Aids, 1 Rheology Modifiers

DIGITAL CONTENT

2 NEWS #PharmaBuzz

2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

4 All

01 4Viibryd/Fetzima

List of Suppliers

Product Main Page

01

Brand Name : Viibryd/Fetzima

The Generic Rx Session

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 336

2016 Revenue in Millions : 342

Growth (%) : -2

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Viibryd/Fetzima

The Generic Rx Session

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 350

2017 Revenue in Millions : 336

Growth (%) : 4%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Viibryd/Fetzima

The Generic Rx Session

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 342

2015 Revenue in Millions : 328

Growth (%) : 4

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Viibryd/Fetzima

The Generic Rx Session

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 424

2018 Revenue in Millions : 350

Growth (%) : 21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info